期刊
CANCER LETTERS
卷 293, 期 2, 页码 144-157出版社
ELSEVIER IRELAND LTD
DOI: 10.1016/j.canlet.2010.01.015
关键词
MYCN; Microarrays; Neuroblastoma; Target genes
类别
资金
- Cancer Research, UK
- Department of Health Clinician Scientist Award
- National Health and Medical Research Council of Australia
- Cancer Institute New South Wales
- Cure for Life Foundation
- Cancer Council New South Wales
The MYCN oncogene encodes a transcription factor which is amplified in up to 40% of high risk neuroblastomas. MYCN amplification is a well-established poor prognostic marker in neuroblastoma, however the role of MYCN expression and the mechanisms by which it acts to promote an aggressive phenotype remain largely unknown. This review discusses the current evidence identifying the direct and indirect downstream transcriptional targets of MYCN from recent studies, with particular reference to how MYCN affects the cell cycle, DNA damage response, differentiation and apoptosis in neuroblastoma. (C) 2010 Elsevier Ireland Ltd. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据